| Eric J Sorscher, MD | |
|
619 19th Street South, Birmingham, AL 35233 | |
| (205) 934-6600 | |
| Not Available |
| Full Name | Eric J Sorscher |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 619 19th Street South, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962421842 | NPI | - | NPPES |
| 38396 | Other | AL | HEALTHSPRING OF ALABAMA |
| 000081490 | Medicaid | AL | |
| 110035807 | Other | AL | RAILROAD MEDICARE |
| E32798 | Other | AL | VIVA |
| 051515815 | Other | AL | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 15013 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Eric J Sorscher, MD Po Box 55310, Birmingham, AL 35255-5310 Ph: (205) 731-9701 | Eric J Sorscher, MD 619 19th Street South, Birmingham, AL 35233 Ph: (205) 934-6600 |
News Archive
Obese women were better able to identify cues that predict monetary rewards than those that predict food rewards, according to a study by Yale School of Medicine researchers and their colleagues in the journal Current Biology. The findings could result in specific behavioral interventions to treat obesity.
Silence Therapeutics plc, a leading international RNAi therapeutics company, is pleased to note that its partner, Quark Pharmaceuticals, Inc., has announced the grant of an option to Novartis to obtain an exclusive worldwide license to develop and commercialise QPI-1002, a p53 temporary inhibitor siRNA drug which incorporates Silence's AtuRNAi technology.
Because the incidence of malignant melanoma is rising faster than any other cancer in the U.S., researchers at Moffitt Cancer Center in Tampa, Fla., and colleagues at Tampa-based Intezyne Technologies, Inc., Western Carolina University and the University of Arizona are working overtime to develop new technologies to aid in both malignant melanoma diagnosis and therapy.
Faculty members from the Indiana University School of Public Health-Bloomington and the school's Center for Sexual Health Promotion recently published a paper in the Journal of Sex & Marital Therapy focused on addressing gaps in scientific understanding of women's sexual pleasure.
Researchers at the University of Arizona have developed a prototype of a new microscope technology that could help surgeons work with a greater degree of accuracy. The new technology, call augmented microscopy, overlays images depicting diagnostic information such as blood flow and cancerous tissue over real images of blood vessels and other tissues and structures being viewed in the microscope.
› Verified 4 days ago
Juan Mario Bernal, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3680 Grandview Pkwy Ste 200, Birmingham, AL 35243 Phone: 205-971-7500 | |
Dr. William Randolph Maddox, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 701 Princeton Ave Sw, Birmingham, AL 35211 Phone: 205-783-3000 Fax: 205-297-9411 | |
Jodie Ann Dionne, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 703 19th St S Bldg 206, Birmingham, AL 35233 Phone: 205-975-6530 | |
Dr. Karl Tullio Schroeder, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 817 Princeton Ave Sw Ste 199, Birmingham, AL 35211 Phone: 205-780-1920 Fax: 205-780-2345 | |
Dr. Deepti Bahl, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 2000 6th Ave S, Birmingham, AL 35233 Phone: 205-934-9999 | |
Amitkumar Mehta, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1720 2nd Ave S # Np2540t, Birmingham, AL 35294 Phone: 205-996-8400 Fax: 205-934-1608 | |
Shana Monika Machado, D.O. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-934-4011 |